Development and validation of an interpretable machine learning model for predicting atrial fibrillation risk in middle-aged and older patients with coronary heart disease - Report - MDSpire

Development and validation of an interpretable machine learning model for predicting atrial fibrillation risk in middle-aged and older patients with coronary heart disease

  • By

  • Feng Chen

  • Qin Fu

  • Ling Li

  • Xiao Zhang

  • Yongqiong Ge

  • Jianfei Chen

  • July 8, 2026

  • 0 min

Share

Clinical Report: Explainable Machine Learning for Atrial Fibrillation Risk Forecasting

Overview

This study developed an interpretable machine learning model to predict atrial fibrillation (AF) risk in middle-aged and elderly patients with coronary heart disease (CHD). The XGBoost model was evaluated for its performance in predicting AF risk.

Background

Coronary heart disease (CHD) and atrial fibrillation (AF) often coexist, complicating patient management and worsening clinical outcomes. Current risk stratification tools inadequately address the complex interactions of risk factors in this population. There is a need for predictive models that can leverage electronic medical records to identify high-risk individuals.

Data Highlights

The study analyzed a cohort of 47,617 hospitalized CHD patients. Key findings include:

Key Findings

  • LASSO regression identified 16 predictors for AF risk, with pulse rate and total cholesterol among the top contributors.
  • The XGBoost model achieved an AUC of 0.867 (95% CI: 0.862–0.872) in the training set.
  • In the validation set, the model maintained an AUC of 0.813 (95% CI: 0.802–0.823).
  • Restricted cubic spline analysis indicated nonlinear dose–response relationships for several continuous variables.
  • SHAP and LIME methods were utilized for model interpretability, providing insights into individual feature contributions.

Clinical Implications

The developed XGBoost model provides a data-driven approach for AF risk assessment in CHD patients.

Conclusion

This study presents a machine learning framework for predicting AF risk in CHD patients.

Related Resources & Content

  1. npj Digital Medicine, 2026 -- A deep learning model integrating structured data and clinical text for predicting atrial fibrillation recurrence
  2. Frontiers in Cardiovascular Medicine, 2026 -- Atrial Fibrillation Type-Specific Prediction of Recurrence After Catheter Ablation: The Pivotal Role of Right Atrial Remodeling Revealed by Explainable Machine Learning
  3. Clinical Research in Cardiology, 2022 -- Utilizing Machine Learning for Identifying and Managing Atrial Fibrillation
  4. Frontiers in Cardiovascular Medicine, 2026 -- Intracardiac thrombus formations despite continuous oral anticoagulation in atrial fibrillation patients undergoing catheter ablation procedures: pilot development of a machine learning prediction model
  5. 2024 Atrial Fibrillation -- ESC Guidelines
  6. BMC Cardiovascular Disorders, 2025 -- The incidence and risk factor of atrial fibrillation after percutaneous coronary intervention
  7. American Heart Association -- Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, & Tools for Risk of Cardiovascular Disease
  8. 2024 Atrial Fibrillation
  9. The incidence and risk factor of atrial fibrillation after percutaneous coronary intervention | BMC Cardiovascular Disorders | Springer Nature Link
  10. Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, & Tools for Risk of Cardiovascular Disease - Professional Heart Daily | American Heart Association

Original Source(s)

Related Content